MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND
Onco hires U.S. bank as capital market adviser
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Aptose's Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
Tempramed enters distribution partnership with Salomo
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg
Correction to MyndTec Inc. Press Release Issued December 3, 2025 Regarding Non-Brokered Private Placement
Apolo V Acquisition Corp. and TelyRx, Inc. Enter into Letter of Intent to Complete Qualifying Transaction
Vitalist Secures Facer for VitalOS
Betterlife talks up BETR-001 benefits
Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine(TM) as a Promising New Anti-Inflammatory Agent
Rocket Doctor Announces First in Canada Strategic Partnership with Toronto Metropolitan University to Support Clinical Education of Medical Learners on a Digital Health Platform
BetterLife Pharma Highlights Advantages of BETR-001 -- a Potent Neuroplastogen
PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results